Accepted Manuscript A novel rotation generator of hydrodynamic cavitation for waste-activated sludge disintegration A novel rotation generator of hydrodynamic cavitation for waste-activated sludge disintegration

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. A novel rotation generator of hydrodynamic cavitation for waste-activated sludge disintegration Abstract The disintegration of raw sludge is very important for enhancement of the biogas production in anaerobic digestion process as it provides easily degradable substrate for microorganisms to perform maximum sludge treatment efficiency and stable digestion of sludge at lower costs. In the present study the disintegration was studied by using a novel rotation generator of hydrodynamic cavitation (RGHC). At the first stage the analysis of hydrodynamics of the RGHC were made with tap water, where the cavitation extent and aggressiveness was evaluated. At the second stage RGHC was used as a tool for pretreatment of a waste-activated sludge (WAS), collected from wastewater treatment plant (WWTP). In case of WAS the disintegration rate was measured, where the soluble chemical oxygen demand (SCOD) and soluble Kjeldahl nitrogen were monitored and microbiological pictures were taken. The SCOD increased from initial 45 mg/L up to 602 mg/L and 12.7 % more biogas has been produced by 20 passes through RGHC. The results were obtained on a pilot bioreactor plant, volume of 400 liters

First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples

The results of an inter-laboratory comparison exercise to determine cytostatic anticancer drug residues in surface water, hospital wastewater and wastewater treatment plant effluent are reported. To obtain a critical number of participants, an invitation was sent out to potential laboratories identified to have the necessary knowledge and instrumentation. Nine laboratories worldwide confirmed their participation in the exercise. The compounds selected (based on the extent of use and laboratories capabilities) included cyclophosphamide, ifosfamide, 5-fluorouracil, gemcitabine, etoposide, methotrexate and cisplatinum. Samples of spiked waste (hospital and wastewater treatment plant effluent) and surface water, and additional non-spiked hospital wastewater, were prepared by the organising laboratory (Jožef Stefan Institute) and sent out to each participant partner for analysis. All analytical methods included solid phase extraction (SPE) and the use of surrogate/internal standards for quantification. Chemical analysis was performed using either liquid or gas chromatography mass (MS) or tandem mass (MS/MS) spectrometry. Cisplatinum was determined using inductively coupled plasma mass spectrometry (ICP-MS). A required minimum contribution of five laboratories meant that only cyclophosphamide, ifosfamide, methotrexate and etoposide could be included in the statistical evaluation. z-score and Q test revealed 3 and 4 outliers using classical and robust approach, respectively. The smallest absolute differences between the spiked values and the measured values were observed in the surface water matrix. The highest within-laboratory repeatability was observed for methotrexate in all three matrices (CV ≤ 12 %). Overall, inter-laboratory reproducibility was poor for all compounds and matrices (CV 27–143 %) with the only exception being methotrexate measured in the spiked hospital wastewater (CV = 8 %). Random and total errors were identified by means of Youden plots